Literature DB >> 19517080

[(Re)habilitation after cochlear implantation].

G Diller1.   

Abstract

Over the last years, indications for cochlear implants (CIs) have changed dramatically. The benefits depend on the preconditions of the individual patient as well as on the subsequent (re)habilitation. Therefore, many variables influencing the hearing and speech perception of a CI user must be kept in mind. As an example, the special situation of children having Turkish as their mother tongue is described. The most convincing argument concerning (re)habilitation is its benefit. Indeed, this benefit represents the final standard of quality and serves as the yardstick for standard assessments of (re)habilitation quality. CI (re)habilitation includes medical, pedagogical, audiological, hearing and speech, and psychological therapeutic aspects.

Entities:  

Mesh:

Year:  2009        PMID: 19517080     DOI: 10.1007/s00106-009-1922-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  5 in total

1.  [Auditory group therapy in adult cochlear implant rehabilitation].

Authors:  C Glaubitz; E K Lehmann; L Weber; A-M Kulke; U Hoppe
Journal:  HNO       Date:  2019-08       Impact factor: 1.284

Review 2.  Cochlear Implantation.

Authors:  Stefan Dazert; Jan Peter Thomas; Andreas Loth; Thomas Zahnert; Timo Stöver
Journal:  Dtsch Arztebl Int       Date:  2020-10-09       Impact factor: 5.594

3.  [Dance projects as an integral part of CI rehabilitation and their impact on mental health: a pilot study].

Authors:  B Klink; M Praetorius; S Roder; M Hintermair
Journal:  HNO       Date:  2014-07       Impact factor: 1.284

4.  [Rehabilitation in children and adults : An overview].

Authors:  A Illg
Journal:  HNO       Date:  2017-07       Impact factor: 1.284

5.  [New ways in hearing rehabilitation after cochlear implantation].

Authors:  C Völter; C Schirmer; M Röber; D Hinsen; S Dazert; K Bilda
Journal:  HNO       Date:  2021-01       Impact factor: 1.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.